Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3406 EUR | -0.58% |
|
-.--% | -45.94% |
Jun. 27 | NeuBase Therapeutics, Inc. Announces Board Resignations | CI |
May. 29 | NeuBase Therapeutics, Inc. announced that it has received $0.000001 million in funding | CI |
Business Summary
Number of employees: 37
Managers
Managers | Title | Age | Since |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 22-01-09 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 21-10-31 |
Alan Scrivner
LAW | General Counsel | - | 21-08-31 |
Shannon McCarthy
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 19-07-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,751,590 | 3,249,699 ( 86.62 %) | 0 | 86.62 % |
Company contact information
NeuBase Therapeutics, Inc.
350 Technology Drive Suite 421
15219, Pittsburgh
+
http://www.neubasetherapeutics.com![address NeuBase Therapeutics, Inc.(O7P)](https://cdn.zonebourse.com/static/address/62120068.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-45.94% | 1.39M | |
+21.87% | 45.01B | |
+47.19% | 40.96B | |
-6.05% | 38.62B | |
+35.72% | 32.6B | |
-7.79% | 27.49B | |
+17.78% | 27.17B | |
+48.16% | 14.61B | |
+40.30% | 12.95B | |
-2.36% | 11.36B |
- Stock Market
- Equities
- O7P Stock
- Company NeuBase Therapeutics, Inc.